Motivating Latino caregivers of children with asthma to quit smoking: a randomized trial.

Centers for Behavioral and Preventive Medicine, The Warren Alpert Medical School of Brown University, Coro Building-West, One Hoppin Street, Suite 500, Providence, RI 02903, USA.
Journal of Consulting and Clinical Psychology (Impact Factor: 4.85). 02/2010; 78(1):34-43. DOI: 10.1037/a0016932
Source: PubMed

ABSTRACT Secondhand smoke exposure is associated with asthma onset and exacerbation. Latino children have higher rates of asthma morbidity than other groups. The current study compared the effectiveness of a newly developed smoking cessation treatment with existing clinical guidelines for smoking cessation.
Latino caregivers who smoked (N = 133; 72.9% female; mean age = 36.8 years) and had a child with asthma were randomly assigned to receive 1 of 2 smoking cessation counseling interventions during a home-based asthma program: (a) behavioral action model (BAM; modeled on clinical guidelines for smoking cessation) or (b) precaution adoption model (PAM; feedback on the caregiver's carbon monoxide level and child's secondhand smoke exposure using Motivational Interviewing). Counseling was delivered by a bilingual Latina health educator, and the content was tailored to Latino values and culture. It was not necessary for smokers to want to quit smoking to participate. Smoking cessation was biochemically verified and secondhand smoke exposure was objectively measured through passive nicotine monitors.
Intent-to-treat analyses showed that 20.5% of participants in the PAM condition and 9.1% of those in the BAM condition were continuously abstinent at 2 months posttreatment (OR = 2.54; 95% CI = 0.91-7.10), whereas 19.1% of participants in the PAM condition and 12.3% of those in BAM condition were continuously abstinent at 3 months posttreatment (OR = 1.68; 95% CI = 0.64-4.37). Secondhand smoke exposure decreased only in the BAM condition (p < .001), an effect due to less smoking around the child among nonquitters in this condition. Asthma morbidity showed significant decreases in the posttreatment period for the PAM group only (p < .001).
Results provide support for targeting specific populations with theory-based interventions.


Available from: Sally Katharine Hammond, Aug 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to systematically review recent empirical literature on smoking cessation in racial/ethnic minority groups. Specifically, we focused on smoking cessation intervention trials and investigations of factors associated with cessation. Studies published between 2010 and September 2014 were considered. Nine smoking cessation intervention trials and 16 studies examining correlates of smoking behavior were published in within the past 3 years. Results demonstrated promise for varenicline in facilitating cessation among African Americans and Hispanics, and culturally specific behavioral counseling appears to be efficacious among Asian Americans. In trans-group comparisons, racial/ethnic minorities reported greater quit attempts compared to Whites; yet success may be reduced due to factors such as menthol smoking, low pharmacotherapy use, and lower readiness to quit. Recommendations for evidence-based interventions and future research are offered.
    03/2015; 2(1). DOI:10.1007/s40429-015-0041-3
  • Education and Information Technologies 01/2014; DOI:10.1007/s10639-014-9349-1
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Secondhand smoke (SHS) is a significant cause of acute respiratory illness (ARI) and 5 times more common in indigenous children. A single-blind randomized trial was undertaken to determine the efficacy of a family centered SHS intervention to reduce ARI in indigenous infants in Australia and New Zealand. Methods: Indigenous mothers/infants from homes with ≥1 smoker were randomized to a SHS intervention involving 3 home visits in the first 3 months of the infants’ lives (plus usual care) or usual care. The primary outcome was number of ARI-related visits to a health provider in the first year of life. Secondary outcomes, assessed at 4 and 12 months of age, included ARI hospitalization rates and mothers’ report of infants’ SHS exposure (validated by urinary cotinine/creatinine ratios [CCRs]), smoking restrictions, and smoking cessation. Results: Two hundred and ninety-three mother/infant dyads were randomized and followed up. Three quarters of mothers smoked during pregnancy and two thirds were smoking at baseline (as were their partners), with no change for more than 12 months. Reported infant exposure to SHS was low (≥95% had smoke-free homes/cars). Infant CCRs were higher if one or both parents were smokers and if mothers breast fed their infants. There was no effect of the intervention on ARI events [471 intervention vs. 438 usual care (reference); incidence rate ratio = 1.10, 95% confidence intervals (CI) = 0.88–1.37, p = .40]. Conclusions: Despite reporting smoke-free homes/cars, mothers and their partners continue to smoke in the first year of infants’ lives, exposing them to SHS. Emphasis needs to be placed on supporting parents to stop smoking preconception, during pregnancy, and postnatal.
    Nicotine & Tobacco Research 08/2014; 17(1). DOI:10.1093/ntr/ntu128 · 2.81 Impact Factor